Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Aeroscena® Featured in 2019 Global Wellness Trends Report for Aromatherapy Innovations

Aeroscena® is pleased to announce their inclusion in the 2019 Global Wellness Trends Report. The featured article, entitled "Mediscent: Fragrance Gets a Makeover," details the company's unique contributions to the understanding of the science of scent as it applies to clinical aromatherapy and phytoinhalants. The report is a publication offered by the leadership of the Global Wellness Summit in concert with their by-invitation-only annual meeting, which this year is currently scheduled for October 15-17 in Hong Kong.


News provided by

Aeroscena

Mar 14, 2019, 09:00 ET

Share this article

Share toX

Share this article

Share toX


CLEVELAND, March 14, 2019 /PRNewswire-PRWeb/ -- Aeroscena® was recently featured in the 2019 Global Wellness Trends Report in an article entitled "Mediscent: Fragrance Gets a Makeover." The article details ways in which scent is influencing wellness trends across multiple industries and environments, including medical, hospitality, travel and personal care, as well as product and brand marketing. Aeroscena® was highlighted as a pioneering force for clinical aromatherapy in the United States, where its medical use and acceptance has faced more significant hurdles than in other countries, in particular, those in Western Europe. The article states:

"Companies like Aeroscena®, based in Cleveland Clinic's Innovations Lab, are literally redefining and relabeling aromatherapy. The company has trademarked the term "phyto-inhalants™" to describe its line of plant-based aromatherapeutics formulated to specifically treat health symptoms, such as pain, nausea and anxiety."

The article notes Aeroscena®’s leadership position in the area of “Aromatherapy 2.0” or “Scent as Medicine” -- a new way of looking at scent’s wellness effects, utilizing evidence-based statements. This 'second wave' view...relies on scientific studies to legitimize aromatherapy's health benefits.

Post this

The article also notes Aeroscena®'s leadership position in the area of "Aromatherapy 2.0" or "Scent as Medicine" -- a new way of looking at scent's wellness effects, utilizing evidence-based statements. This "second wave" view of aromatherapy relies on scientific studies carried out in controlled hospital and clinical settings, rather than folklore and hearsay, to demonstrate and legitimize aromatherapy's positive health benefits.

In fact, dozens of hospitals and specialty treatment centers around the country, including Moffitt Cancer Center and Virginia Commonwealth University, are already utilizing Aeroscena®'s Ascents® personal aromatherapy inhalers as an adjunct treatment option to mitigate symptoms and side-effects of illnesses or medications, such as nausea, insomnia and anxiety for their patients.

Aeroscena®'s relationship with indoor wellness thought leader Delos Living is mentioned as well, shining a spotlight on the company's inclusion in Delos' Stay Well™ Shop. The online store currently offers a range of products curated by Delos, such as Aeroscena®'s Ascents® clinical aromatherapy diffuser systems and patented essential oil gel pods, that promote a healthier indoor environment.

Ascents® diffusers and gels are currently placed in Delos' signature Stay Well™ suites, an upgraded room category available when staying with some of the most respected hotel brands in the world, including MGM, Wyndham, and Marriott International. Further expansion of the program is expected both domestically and internationally.

Ascents® systems are often selected as the scenting option of choice for hospitality applications due to the 100% natural, patented dry gel technology utilized to control the diffusion of essential oils into the air. These gels are the first of their kind, requiring no water or heat to activate; therefore, the diffusion process does not alter the delicate, therapeutic compounds contained in the scientifically formulated blends in any way. It produces no smoke or ozone, resulting in an exceptionally clean diffusion, making them an excellent choice to naturally scent hotel rooms or provide an aromatherapeutic touch to suites for discerning travelers.

Aeroscena® looks forward to continuing to bridge the gap between science and scent for the sake of wellness in both clinical and commercial environments as the company moves through 2019 and beyond.

About Aeroscena®, LLC

Established in 2010, Aeroscena® is the parent company and research and development organization behind Ascents®-branded clinical aromatherapy formulas. Ascents® formulas are the only aromatherapy products that are recommended by doctors, used by hospitals®. Aeroscena® is located in the Cleveland Clinic Global Cardiovascular Innovations Center in Cleveland, OH. For more information about Ascents®, visit https://www.shopascents.com. For more information about Aeroscena®, visit https://www.aeroscena.com or contact the company via phone at (800) 671-1890.

SOURCE Aeroscena

Modal title

Aeroscena® -- The Global Leader in Clinical Aromatherapy
Aeroscena® -- The Global Leader in Clinical Aromatherapy
Ascents®: Clinical Aromatherapy Recommended by Doctors, Used by Hospitals
Ascents®: Clinical Aromatherapy Recommended by Doctors, Used by Hospitals
Fresh No. 11 Aromatherapy Diffuser System
Fresh No. 11 Aromatherapy Diffuser System
Nausea Relief No. 44 Personal Aromatherapy Inhaler
Nausea Relief No. 44 Personal Aromatherapy Inhaler
Aeroscena® -- The Global Leader in Clinical Aromatherapy Ascents®: Clinical Aromatherapy Recommended by Doctors, Used by Hospitals Fresh No. 11 Aromatherapy Diffuser System Nausea Relief No. 44 Personal Aromatherapy Inhaler

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.